Navigation Links
Prostate cancer biomarkers identified in seminal fluid
Date:6/6/2014

Improved diagnosis and management of one of the most common cancers in men prostate cancer could result from research at the University of Adelaide, which has discovered that seminal fluid (semen) contains biomarkers for the disease.

Results of a study now published in the journal Endocrine-Related Cancer have shown that the presence of certain molecules in seminal fluid indicates not only whether a man has prostate cancer, but also the severity of the cancer.

Speaking in the lead-up to Men's Health Week (9-15 June), University of Adelaide research fellow and lead author Dr Luke Selth says the commonly used PSA (prostate specific antigen) test is by itself not ideal to test for the cancer.

"While the PSA test is very sensitive, it is not highly specific for prostate cancer," Dr Selth says. "This results in many unnecessary biopsies of non-malignant disease. More problematically, PSA testing has resulted in substantial over-diagnosis and over-treatment of slow growing, non-lethal prostate cancers that could have been safely left alone.

"Biomarkers that can accurately detect prostate cancer at an early stage and identify aggressive tumors are urgently needed to improve patient care. Identification of such biomarkers is a major focus of our research," he says.

Dr Selth, a Young Investigator of the Prostate Cancer Foundation (USA), is a member of the Freemasons Foundation Centre for Men's Health at the University of Adelaide and is based in the University's Dame Roma Mitchell Cancer Research Laboratories.

Using samples from 60 men, Dr Selth and colleagues discovered a number of small ribonucleic acid (RNA) molecules called microRNAs in seminal fluid that are known to be increased in prostate tumors. The study showed that some of these microRNAs were surprisingly accurate in detecting cancer.

"The presence of these microRNAs enabled us to more accurately discriminate between patients who had cancer and those who didn't, compared with a standard PSA test," Dr Selth says. "We also found that the one specific microRNA, miR-200b, could distinguish between men with low grade and higher grade tumors. This is important because, as a potential prognostic tool, it will help to indicate the urgency and type of treatment required."

This research builds on previous work by Dr Selth's team, published in the British Journal of Cancer, which demonstrated that microRNAs in the blood can predict men who are likely to relapse after surgical removal of their prostate cancer. "We are excited by the potential clinical application of microRNAs in a range of body fluids," he says.


'/>"/>

Contact: Dr. Luke Selth
luke.selth@adelaide.edu.au
61-882-223-618
University of Adelaide
Source:Eurekalert

Related biology news :

1. Circumcision linked to reduced risk of prostate cancer in some men
2. Prostate cancer and blood lipids share genetic links
3. Circumcision could prevent prostate cancer... if its performed after the age of 35
4. A gene family that suppresses prostate cancer
5. CNIO researcher awarded by the Prostate Cancer Foundation
6. Cholesterol study suggests new diagnostic, treatment approach for prostate cancer
7. Targeting metabolism to develop new prostate cancer treatments
8. Myriads Prolaris significantly modifies treatment decisions for prostate cancer patients
9. Mechanism affecting risk of prostate cancer is found
10. Genetic mutation may play key role in risk of lethal prostate cancer in overweight patients
11. Men with prostate cancer who ate a low-fat fish oil diet showed changes in their cancer tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2016)... --> --> ... and Access Management Market by Component (Provisioning, Directory Services, ... Organization Size, by Deployment, by Vertical, and by Region ... market is estimated to grow from USD 7.20 Billion ... a Compound Annual Growth Rate (CAGR) of 12.2% during ...
(Date:3/9/2016)... , March 9, 2016 This BCC ... future states of the RNA Sequencing (RNA Seq) market ... such as instruments, tools and reagents, data analysis, and ... various segments of the RNA-Sequencing market such as RNA-Sequencing ... Identify the main factors affecting each segment and forecast ...
(Date:3/9/2016)... 9, 2016  Crossmatch ® , a leading ... today announced the addition of smart features to ... multi-factor authentication platform. New contextual and application-specific authentication ... security where it,s needed most — while minimizing ... . --> Washington, DC ...
Breaking Biology News(10 mins):
(Date:5/17/2016)... ... May 17, 2016 , ... DryLet, ... reduction applications, announced today it will be showcasing ManureMagic™ at booth V1061 at ... featured in the Wall Street Journal last year and more recently made news ...
(Date:5/17/2016)... ... May 17, 2016 , ... PATH and Laerdal Global ... to bring a feeding cup to market based on a reference design co-developed ... at Seattle Children’s Hospital, thereby ensuring an innovative feeding option for the 7.6 ...
(Date:5/17/2016)... 17, 2016 Strekin AG, ... Basel, Switzerland announced today the ... P38 mitogen-activated protein kinase.      (Logo: ... will build the necessary research foundation for the ... MAP Kinases play fundamental roles. Pamapimod has a ...
(Date:5/17/2016)... Durham, NC (PRWEB) , ... May 17, 2016 ... ... preparation and delivery devices was recently selected by BD (Becton, Dickinson and Company) ... BD Supplier Recognition Program honors those suppliers who have made significant contributions to ...
Breaking Biology Technology: